View Author
migration emap-ii tumour assay factor cancer protein tumor expression effect tnf-r proemap treatment tnf-r 1 cell migration e-cadherin activity patient necrosis limb perfusion response melanoma study perfusion tumour cells growth figure motility barrier sarcoma control proemap /p breast cytokine tumour necrosis factor proemap /p cleavage tissue movie cleavage capacity experiment result membrane tnf-r 1 expression matrix medium apoptosi cell lines actin melphalan analysis fibroblast eggermont huvec vessel tumours distance polypeptide novel growth factors adhesion scratch monocyte-activating polypeptide ii process difference tumor necrosis factor caspase tradd staining tnf -α mechanism level receptor image clasp addition movement time-lapse phase-contrast microscopy chapter mmp -7
8 Most Recent Publications
|
E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells
(Article)
Horssen, R. van Hollestelle, A. Rens, J.A.P. Eggermont, A.M.M. Schutte, A.E.M. Hagen, T.L.M.T. |
2012-11-01
|
|
Crossing barriers: The new dimension of 2D cell migration assays
(Article)
Horssen, R. van Hagen, T.L.M. ten |
2011-01-01
|
|
Local ATP generation by brain-type creatine kinase (CK-B) facilities cell motility
(Article)
Kuiper, J.W.P. Horssen, R. van Oerlemans, F. Peters, W. Dommelen, M.M.T. van Lindert, M.M. te Hagen, T.L.M. ten Janssen, E. Fransen, J.A.M. Wieringa, B. |
2009-03-31
|
|
Modulation of cell motility by spatial repositioning of enzymatic ATP/ADP Exchange capacity
(Article)
Horssen, R. van Janssen, E. Peters, W. Pasch, L.D. van Lindert, M.M. te Dommelen, M.M.T. van Linssen, P.C. Hagen, T.L.M. ten Fransen, J.A.M. Wieringa, B. |
2009-01-16
|
|
Cytokine detection in cells and tissues: Complicated lessons from proEMAP/p43 and EMAP-II
(Article)
Horssen, R. van Rens, J.A.P. Hagen, T.L.M. ten |
2008-07-01
|
|
Tumor Motility: Cell migration analysis and effects of EMAP-II on TNF antitumour activities
(Doctoral Thesis)
Horssen, R. van |
2006-09-06
|
|
TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility.
(Article)
Horssen, R. van Hagen, T.L.M. ten Eggermont, A.M.M. |
2006-04-01
|
|
Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcoma
(Article)
Lans, T.E. Hagen, T.L.M. ten Horssen, R. van Wu, P.C. Tiel, S.T. van Libutti, S.K. Alexander, H.R. Eggermont, A.M.M. |
2002-01-01
|
